SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 31.91+1.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Trumptown who wrote (186)7/13/1997 12:24:00 PM
From: Douglas   of 455
 
I FOUND ANOTHER COMPANY THAT PARAMOUNT HAS BOUGHT A LARGE NUMBER OF SHARES THIS YEAR. THE COMPANY IS REPLIGEN CORPORATION (RGEN). FROM MARCH TO APRIL OF 1997, PARAMOUNT HAS BOUGHT 1,408,100 SHARES FOR ARIES TRUST AND 664,600 SHARES FOR ARIES DOMESTIC FUND. THE PURCHASE PRICE RANGED FROM $1.13 TO $1.50. REPLIGEN CORP. IS A BIOPHARMACEUTICAL COMPANY THAT RESEARCHES, DEVELOPS, AND MANUFACTURES THERAPEUTIC PRODUCTS FOR HUMAN HEALTH CARE. THEY CURRENTLY HAVE 16.008 MILLION SHARES OUTSTANDING. WHAT IS INTERESTING IS THAT ON AUGUST 1, 1996 THE COMPANY'S SHARE PRICE WAS 50 CENTS. RGEN IS NOW TRADING ABOUT $1.00. DURING FY 96, REPLIGEN COMPLETED A MAJOR DOWNSIZING AND CONSOLIDATION OF ITS OPERATION, WHICH INCLUDED SUBSTANTIAL WORKFORCE REDUCTIONS, TERMINATION OF SEVERAL RESEARCH PROGRAMS AND THE CLOSING OF A RESEARCH AND MANUFACTURING FACILITY. SOUNDS LIKE PROCEPT. I WONDER IF A PRIVATE PLACEMENT AT RGEN IS IN THE WORKS?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext